FDA Approved: DEFERASIROX — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved the original application for deferasirox (DEFERASIROX) from Zydus Pharmaceuticals USA Inc., providing a generic oral iron chelator for chronic tran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload Due to Chronic Transfusion Therapy

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)